Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models

Jungen Hu, Tianxu Liu, Mara Klöhn, Andrew Freistaedter, Elif Toprak, Huanting Chi, André Gömer, Lilli Pottkaemper, Paula Jordan, Xinyue Yang, He Zhang, Johanna Becker, Shirin Nkongolo, Volker Lohmann, Eike Steinmann, Lin Wang, Viet Loan Dao Thi

Open source

DOI
10.1136/gutjnl-2025-336714
Published
2026-03-06
Container
Gut
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/gutjnl-2025-336714,
  title = {Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models},
  author = {Jungen Hu and Tianxu Liu and Mara Klöhn and Andrew Freistaedter and Elif Toprak and Huanting Chi and André Gömer and Lilli Pottkaemper and Paula Jordan and Xinyue Yang and He Zhang and Johanna Becker and Shirin Nkongolo and Volker Lohmann and Eike Steinmann and Lin Wang and Viet Loan Dao Thi},
  year = {2026},
  journal = {Gut},
  doi = {10.1136/gutjnl-2025-336714},
  url = {https://doi.org/10.1136/gutjnl-2025-336714}
}

RIS

TY  - JOUR
TI  - Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models
AU  - Jungen Hu
AU  - Tianxu Liu
AU  - Mara Klöhn
AU  - Andrew Freistaedter
AU  - Elif Toprak
AU  - Huanting Chi
AU  - André Gömer
AU  - Lilli Pottkaemper
AU  - Paula Jordan
AU  - Xinyue Yang
AU  - He Zhang
AU  - Johanna Becker
AU  - Shirin Nkongolo
AU  - Volker Lohmann
AU  - Eike Steinmann
AU  - Lin Wang
AU  - Viet Loan Dao Thi
PY  - 2026
JO  - Gut
DO  - 10.1136/gutjnl-2025-336714
UR  - https://doi.org/10.1136/gutjnl-2025-336714
ER  - 

APA

Hu, J., Liu, T., Klöhn, M., Freistaedter, A., Toprak, E., Chi, H., Gömer, A., Pottkaemper, L., Jordan, P., Yang, X., Zhang, H., Becker, J., Nkongolo, S., Lohmann, V., Steinmann, E., Wang, L., & Thi, V. L. D. (2026). Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models. Gut. https://doi.org/10.1136/gutjnl-2025-336714

Source records